Dermata Therapeutics (DRMAW) Stock Chart & Stock Price History $0.02 0.00 (0.00%) As of 08/29/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsFDA EventsSEC FilingsTrendsBuy This Stock Dermata Therapeutics Stock Price Performance The Dermata Therapeutics (DRMAW) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 158.14%, with a year-to-date return of 107.48%. In the past month, the stock has increased 40.51%, reflecting recent market activity. As of the latest close, Dermata Therapeutics traded at $0.02 with a market cap of and volume of 200 shares. Receive DRMAW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+1.37%1 Month Performance+40.51%3 Month Performance+63.24%Year-To-Date Performance+107.48%1 Year Performance+158.14% DRMAW Stock Chart for Monday, September, 1, 2025 DRMAW Chart by TradingView Dermata Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/29/2025$0.02$0.02$0.02$0.02200 shs$0.0008/28/2025$0.02$0.02$0.02$0.02200 shs$0.0008/27/2025$0.02$0.02$0.02$0.024,900 shs$0.0008/26/2025$0.02$0.02+6.83%$0.02$0.024,900 shs$0.0008/25/2025$0.02$0.02-0.49%$0.02$0.024,933 shs$0.0008/22/2025$0.02$0.02-13.08%$0.02$0.029,900 shs$0.0008/21/2025$0.02$0.02+41.92%$0.02$0.029,896 shs$0.0008/20/2025$0.02$0.02$0.02$0.022,100 shs$0.0008/19/2025$0.02$0.02-15.23%$0.02$0.022,100 shs$0.0008/18/2025$0.02$0.02$0.02$0.022,097 shs$0.00 Get the Latest News and Ratings for DRMAW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/15/2025$0.02$0.02-10.05%$0.02$0.025,248 shs$0.0008/14/2025$0.02$0.02+14.66%$0.02$0.025,248 shs$0.0008/13/2025$0.02$0.02+0.53%$0.02$0.0216,486 shs$0.0008/12/2025$0.02$0.02+0.53%$0.02$0.028,556 shs$0.0008/11/2025$0.02$0.02$0.02$0.02200 shs$0.0008/08/2025$0.02$0.02-18.18%$0.02$0.02250 shs$0.0008/07/2025$0.02$0.02+0.43%$0.02$0.028,500 shs$0.0008/06/2025$0.02$0.02$0.02$0.028,500 shs$0.0008/05/2025$0.02$0.02+1.32%$0.02$0.028,500 shs$0.0008/04/2025$0.02$0.02+43.67%$0.02$0.028,500 shs$0.0008/01/2025$0.02$0.02-16.40%$0.02$0.028,595 shs$0.0007/31/2025$0.02$0.02-3.57%$0.02$0.0219,613 shs$0.00 Related Companies ATNFW Stock Chart LBPSW Stock Chart AEHAW Stock Chart AIMDW Stock Chart ALVOW Stock Chart ARAV Stock Chart ACABW Stock Chart BFRIW Stock Chart BTMDW Stock Chart BCTXW Stock Chart Receive DRMAW Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DRMAW) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dermata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dermata Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DRMAW Stock Alerts